Sfbc (NASDAQ:SFCC)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Sfbc Charts. Click Here for more Sfbc Charts.](/p.php?pid=staticchart&s=N%5ESFCC&p=8&t=15)
SFBC International, Inc. (NASDAQ:SFCC), a provider of
drug development services to branded pharmaceutical, biotechnology,
generic drug and medical device companies, announced today that it
plans to release its financial results for the fourth quarter and full
year 2005 on Thursday, March 2, 2006, after the market closes. In
addition, the Company plans to host a conference call and Webcast to
review the results at 8:30 a.m. Eastern Time on Friday, March 3, 2006.
To access the conference call, please dial the following
teleconference number (877) 691-0878 (U.S.) or (973) 582-2773
(International) or to listen to the simultaneous Webcast, please visit
http://www.sfbci.com.
For those unable to access the live conference, there will be an
audio replay available from March 3, 2006 at approximately 11:00 a.m.
Eastern Time through March 17, 2006 at 11:59 p.m. Eastern Time. To
listen to the audio replay, please dial (877) 519-4471 (U.S.) or (973)
341-3080 (International) and use the following replay pin code:
7081622. A replay of the live Webcast will also be available at
http://www.sfbci.com approximately two hours after the live call ends
through April 2, 2006 at 11:59 p.m. Eastern Time.
About SFBC International, Inc.
SFBC International, Inc. provides early through late stage
clinical drug development services to branded pharmaceutical,
biotechnology, generic drug and medical device companies around the
world. SFBC has more than 30 offices located in North America, Europe
(including Central and Eastern Europe), South America, Asia, and
Australia. In early clinical development services, SFBC specializes
primarily in the areas of Phase I and early Phase II clinical trials
and bioanalytical laboratory services, including early clinical
pharmacology. SFBC also provides late stage clinical development
services globally that focus on Phase II through IV clinical trials.
SFBC also offers a range of complementary services, including data
management and biostatistics, central laboratory services, medical and
scientific affairs, regulatory affairs and submissions, and clinical
IT solutions. Additional information is available on SFBC's website at
http://www.sfbci.com.